Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis.
about
Risk and Surveillance of Cancers in Primary Biliary Tract DiseaseBrazilian society of hepatology recommendations for the diagnosis and management of autoimmune diseases of the liverDiagnostic and therapeutic biomarkers in pancreaticobiliary malignancyAdvanced endoscopic imaging of indeterminate biliary stricturesHow Should Cancer Surveillance in Primary Sclerosing Cholangitis Be Performed?Current diagnostic and management options in perihilar cholangiocarcinomaCholangiocarcinomaLong-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitisClassification, diagnosis, and management of cholangiocarcinomaUpdate on the Diagnosis and Treatment of Cholangiocarcinoma.Chronic inflammation and cytokines in the tumor microenvironment.Natural History and Prognostic Factors of Advanced Cholangiocarcinoma without Surgery, Chemotherapy, or Radiotherapy: A Large-Scale Observational Study.Analytical review of diagnosis and treatment strategies for dominant bile duct strictures in patients with primary sclerosing cholangitisHepatobiliary complications of inflammatory bowel disease.Primary sclerosing cholangitis: diagnostic and therapeutic problems.New insights on cholangiocarcinoma.Identification of Serum Biomarkers for Biliary Tract Cancers by a Proteomic Approach Based on Time-of-Flight Mass Spectrometry.Biliary multifocal chromosomal polysomy and cholangiocarcinoma in primary sclerosing cholangitisCancer surveillance in patients with primary sclerosing cholangitis.A combination of serum leucine-rich α-2-glycoprotein 1, CA19-9 and interleukin-6 differentiate biliary tract cancer from benign biliary strictures.Circulating CYFRA 21-1 is a Specific Diagnostic and Prognostic Biomarker in Biliary Tract Cancer.Gallstones and cholecystectomy in relation to risk of intra- and extrahepatic cholangiocarcinoma.Approach to a patient with elevated serum alkaline phosphatase.Screening for hepatocellular carcinoma and cholangiocarcinoma: Can biomarkers replace imaging?Systematic review with meta-analysis: endoscopic retrograde cholangiopancreatography-based modalities for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis.Primary Sclerosing Cholangitis as a Premalignant Biliary Tract Disease: Surveillance and Management.Diagnostic Accuracy of Serum CA19-9 in Patients with Cholangiocarcinoma: A Systematic Review and Meta-Analysis.Pyruvate kinase M2 is a novel diagnostic marker and predicts tumor progression in human biliary tract cancerThe Roles of MicroRNA-122 Overexpression in Inhibiting Proliferation and Invasion and Stimulating Apoptosis of Human Cholangiocarcinoma CellsGenetic Abnormalities in Biliary Brush Samples for Distinguishing Cholangiocarcinoma from Benign Strictures in Primary Sclerosing CholangitisPrimary sclerosing cholangitis: diagnosis, prognosis, and management.Malignancies in Primary Sclerosing Cholangitis--A Continuing ThreatPreneoplastic conditions underlying bile duct cancer.Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma.The dynamic biliary epithelia: molecules, pathways, and disease.Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009Hepatobiliary associations with inflammatory bowel disease.Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implicationsTreatment options for primary sclerosing cholangitis.
P2860
Q26740434-F3091AA6-CD65-49C5-A694-B09865C91A66Q26766699-661A68C5-44C0-471C-AF07-F4B608A4DE1BQ26767120-7D38958C-2C23-4D88-8CAC-178075829E90Q26775370-A64D3461-FA74-420E-9BA3-B8868EA4D50BQ26782878-A496E9F0-D886-4758-9A19-AF5FAD8A065DQ26822808-EC087B6F-1868-4697-B352-F69D4619D251Q27001694-4066877B-CDC6-46A1-A5D1-5D80B6554252Q28263151-D76857CA-F44A-48DF-B42B-1DAA412FBCF9Q28275153-0A35AD88-6CA0-48D5-B99E-659251AC7091Q30238895-11D948C8-33AC-454A-A40B-839931C08220Q33678275-DB9C600B-2A36-4E94-9A9A-6468A65A7F27Q33781698-0FBECD59-D367-429D-98BB-B5ECD49239D6Q33795175-655C715C-15C1-4033-860B-F84331E30978Q33966083-7F8F2F37-849E-40B1-AFC6-4498DADD919EQ34079772-16E1639B-925C-40E0-9465-813C0BA5E1AAQ34391135-39060FA4-F508-450A-A9E2-A7DE9B077ED1Q35054649-E7401D42-284C-4B26-8069-6FF4C13FB6D6Q35146460-E4EBA108-DB8E-4AD7-BD3E-11C28A0DD826Q35490961-05004153-5A5C-48CF-B740-E6384C83AECAQ35620650-C4F59E33-5CC1-483B-8E33-F5C7228E9519Q35654552-114AB9AC-DF62-4463-93FD-FC3738B35D2AQ35835127-F25597B3-CAC8-41B8-B161-D9A644D926CBQ35926418-0AD2C8DA-59EE-42F3-89EB-F5D2D441ED46Q36000994-6203CE61-6AE4-4E7E-B519-F5613A9144DDQ36151669-C42A5CFE-2A84-4818-9324-581AE08177C5Q36199767-83EA6B6E-73B9-417C-9472-C300809B135AQ36306293-A84587E9-971F-4AC3-8DE1-12FEAA5F1C60Q36381459-9A60A236-33F4-4FD8-B811-4636FC273A7FQ36388133-502637F1-0084-4985-873A-129311FDEC99Q36805289-FB106135-DBD6-48A4-A900-F8B9B26696ECQ36955053-3E4A36C0-C6D5-4E08-A5BF-BE50454B7938Q37082378-7CFD9C8F-29FE-4568-9FDA-35A22D1F359EQ37246190-4C471580-342D-4E7C-86FE-59DCE2010BDFQ37316693-54ADC078-0324-4322-B8AB-6AC1D2F77660Q37317828-4D450874-5A44-4593-8F71-0D6115FE2BCAQ37347327-375F94A1-ABB5-4B37-8A8B-76DF7674D17AQ37636108-2204506E-FA1E-4633-9C84-FA0A2825E213Q37701805-2999CEBC-CBD7-4400-816B-E0E06CBCB99AQ37706763-7719F851-B6FB-4EF1-A22A-463872105977Q37777156-4384F6E3-19DC-4159-841B-F5C410CDE15E
P2860
Utility of serum tumor markers, imaging, and biliary cytology for detecting cholangiocarcinoma in primary sclerosing cholangitis.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Utility of serum tumor markers ...... rimary sclerosing cholangitis.
@en
Utility of serum tumor markers ...... rimary sclerosing cholangitis.
@nl
type
label
Utility of serum tumor markers ...... rimary sclerosing cholangitis.
@en
Utility of serum tumor markers ...... rimary sclerosing cholangitis.
@nl
prefLabel
Utility of serum tumor markers ...... rimary sclerosing cholangitis.
@en
Utility of serum tumor markers ...... rimary sclerosing cholangitis.
@nl
P2093
P356
P1433
P1476
Utility of serum tumor markers ...... rimary sclerosing cholangitis.
@en
P2093
Keith D Lindor
Kevin C Halling
Phunchai Charatcharoenwitthaya
P304
P356
10.1002/HEP.22441
P407
P577
2008-10-01T00:00:00Z